Author(s): Caitlin Gracie, Abbas Zaidi, Umesh Doobaree, et al. Abstract: S139 Session topic: 33. Platelets disorders Background Rituximab is reported to give response rates, partial or complete, (platelets >30 x109/L and >2 baseline) of up to 60% in patients with ITP. The efficacy of lower doses of rituximab (<375 mg/m2) have been...
Pro zobrazení tohoto obsahu je třeba být přihlášen.